Search Results - P William Conrad

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration by P William Conrad, David N Zacks, Mark W Johnson

    Published in Clinical Ophthalmology (2008-06-01)
    Get full text
    Article


Search Tools: